Literature DB >> 10336861

pSKAP/S: An expression vector for the production of single-chain Fv alkaline phosphatase fusion proteins.

R A Griep1, C van Twisk, R J Kerschbaumer, K Harper, L Torrance, G Himmler, J M van der Wolf, A Schots.   

Abstract

The vector pSKAP/S was constructed to enable overexpression of single-chain variable fragment antibody (scFv)-alkaline phosphatase fusion proteins. In pSKAP/S, the scFv were genetically fused to the mutated Escherichia coli PhoA/S gene that encodes an alkaline phosphatase with increased specific activity. The restriction sites incorporated into pSKAP/S allowed the scFv genes to be easily transferred from pUC119-derived phagemid vectors that are used frequently in phage display antibody library technology. Strong transcriptional control of expression was achieved using the tetracycline promoter, and induction of different individual clones with anhydrotetracycline resulted in secretion of most of the scFv-alkaline phosphatase fusion proteins into the culture medium. Although some of the clones secreted fusion proteins that were retained in the periplasm, these proteins could be isolated with a simple extraction procedure. Increased amounts of a scFv-alkaline phosphatase fusion protein were obtained when expressed in the pSKAP/S vector compared with expression in a vector incorporating the lac promoter. Testing for binding of the scFv-alkaline phosphatase fusion proteins to antigen was possible in an ELISA without the need for additional enzyme-conjugated antibodies. The pSKAP/S vector was successfully used to obtain scFv fragments from a preparation of phage-antibody clones after subcloning and expression of individual clones as scFv-alkaline phosphatase fusions, whereas fewer clones (and clones with different properties) were obtained from the same phage-antibody preparations when expressed as soluble scFv fragments. Therefore, the pSKAP/S vector was shown to be useful in extending the range of scFv obtained from phage display libraries. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10336861     DOI: 10.1006/prep.1999.1041

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  16 in total

Review 1.  The production and application of single-chain antibody fragments.

Authors:  D Blazek; V Celer
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

2.  Chaperone Hsp31 contributes to acid resistance in stationary-phase Escherichia coli.

Authors:  Mirna Mujacic; François Baneyx
Journal:  Appl Environ Microbiol       Date:  2006-12-08       Impact factor: 4.792

3.  Optimization of the crystallizability of a single-chain antibody fragment.

Authors:  Jana Škerlová; Vlastimil Král; Milan Fábry; Juraj Sedláček; Václav Veverka; Pavlína Rezáčová
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-11-14       Impact factor: 1.056

4.  A secretory system for bacterial production of high-profile protein targets.

Authors:  Alexander Kotzsch; Erik Vernet; Martin Hammarström; Jens Berthelsen; Johan Weigelt; Susanne Gräslund; Michael Sundström
Journal:  Protein Sci       Date:  2011-03       Impact factor: 6.725

5.  A Strategy for Generating a Broad-Spectrum Monoclonal Antibody and Soluble Single-Chain Variable Fragments against Plant Potyviruses.

Authors:  Han-Lin Liu; Wei-Fang Lin; Wen-Chi Hu; Yung-An Lee; Ya-Chun Chang
Journal:  Appl Environ Microbiol       Date:  2015-07-24       Impact factor: 4.792

6.  Expression of a Functional zipFv Antibody Fragment and Its Fusions with Alkaline Phosphatase in the Cytoplasm of an Escherichia coli.

Authors:  Byung-Ung Hur; Hyo-Jung Choi; Jae-Bong Yoon; Sang-Hoon Cha
Journal:  Immune Netw       Date:  2010-04-30       Impact factor: 6.303

7.  Recombinatorial cloning using heterologous lox sites.

Authors:  Robert W Siegel; Nileena Velappan; Peter Pavlik; Leslie Chasteen; Andrew Bradbury
Journal:  Genome Res       Date:  2004-06       Impact factor: 9.043

8.  Beyond natural antibodies: the power of in vitro display technologies.

Authors:  Andrew R M Bradbury; Sachdev Sidhu; Stefan Dübel; John McCafferty
Journal:  Nat Biotechnol       Date:  2011-03       Impact factor: 54.908

9.  Fluorescent labeling of antibody fragments using split GFP.

Authors:  Fortunato Ferrara; Pawel Listwan; Geoffrey S Waldo; Andrew R M Bradbury
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

10.  Strategies for successful recombinant expression of disulfide bond-dependent proteins in Escherichia coli.

Authors:  Ario de Marco
Journal:  Microb Cell Fact       Date:  2009-05-14       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.